Meningitis is inflammation of the meninges that are present at the back of your throat. Commonly known as “pneumonia” it is generally caused by viral infections. Meningitis is the inflammation of these tissues. The first symptoms might resemble a cold but develop quickly within just a couple of hours to a couple of days. Moreover, most of the typical meningitis symptoms are present in all instances. The symptoms of Meningitis may include mild headache, fever, and a feeling of tiredness/ fatigue. These symptoms occur more in young adults and are often associated with postnasal drip. Other possible signs and symptoms include: trouble swallowing, swollen glands near the neck, increased sensitivity to hot or cold temperatures, changes in vision, increased sensitivity to light and decreased sense of smell.
Get Free Sample Copy With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-sample/954
According to Meningitis Research Foundation, as of 2017, around 80% – 90% of meningitis cases are estimated to be caused by enteroviruses and the remaining 10% is estimated to be caused by herpes virus, mumps, measles, and human immune deficiency virus. The major causes of bacterial meningitis are Neisseria meningitis (causing meningococcal disease), Haemophilus influenzae type b (causing Hib disease), and Streptococcus pneumonia (causing pneumococcal disease). Prolonged exposure to these bacteria can spread the infection. In 2010, According to the Confederation of Meningitis Organizations Inc., around 50% of the bacterial meningitis cases occur in children under the age of five years and in adolescent and young adults from 15-24 year of age.
Advent of advanced technology to curb infectious diseases is driving meningitis treatment market growth
Growing public and private sectors partnership to increase availability of vaccine to the populace. For instance, Global Alliance for Vaccines and Immunization (GAVIs), an international organization, brings together public and private sectors with a goal to provide access to all the latest vaccines to children in the world’s poorest countries. People with immune compromised diseases such as HIV, diabetes, cancer, and organ transplants are at higher risk of having aseptic meningitis. Moreover, advancements in diagnostics and technological platforms are projected to boost growth of the meningitis treatment market.
For instance, in 2009, venture by Cadila with a U.S.-based vaccine company – Novavax, aimed to develop and manufacture therapeutic and prophylactic vaccines to combat infectious diseases. Advent of new vaccine with enhanced mechanism, and increasing advancement in genetics and immunology are again expected to boost growth of the meningitis treatment market. Moreover, factors such as high incidence rate with major brain injuries due to road accidents are further propelling growth of the market for meningitis treatment worldwide. On the other hand, stringent regulations and alternate medications are factors restricting growth of the meningitis treatment market.
Request PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/954
On the basis of region, the global meningitis treatment market is projected to be the most prominent in the sub-Saharan belt of African, which is again known as the meningitis belt due to higher incidence rate of meningitis C. The second highest incidence rate is recorded in India as reported by the World Health Organization (WHO), 2015. Around 12,000 cases of meningitis C and 800 deaths were recorded in Nigeria, in 2015. This indicates the rising incidence rate of meningitis, which in turn, is expected to propel growth of the meningitis treatment market in the near future.
Global Meningitis treatment market is expected to gain momentum due to high cases of acute meningitis
The key players operating in the meningitis treatment market include Biomed Pvt. Ltd, Novartis, Nuron Biotech, Pfizer, Baxter, Merck & Co., GSK, and Sanofi. The market is gaining momentum owing to current unmet needs of vaccinations and growing incidence of meningitis globally. Joint ventures, partnership, and investment in research and development activities by key companies are again expected to boost growth of the market. For instance, to treat aseptic meningitis, Bristol-Myers Squib is focusing on development of biologics – nivolumab (Opdivo) is in phase 3, and ipilimumab in phase 2.
Meningitis Treatment Market Taxonomy
By Causative Micro-organism
By Treatment Type
- Antibiotic Therapy
- Adjunctive Therapy
By Vaccine Type
- Meningococcal Conjugate Vaccine
- Meningococcal Polysaccharide Vaccine (MPSV4)
- Combination Vaccine
𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐎 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐓𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/954
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Meningitis Treatment Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Meningitis Treatment Industry Impact
Chapter 2 Meningitis Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Meningitis Treatment (Volume and Value) by Type
2.3 Meningitis Treatment (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Meningitis Treatment Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Meningitis Treatment Market Analysis
Chapter 6 East Asia Meningitis Treatment Market Analysis
Chapter 7 Europe Meningitis Treatment Market Analysis
Chapter 8 South Asia Meningitis Treatment Market Analysis
Chapter 9 Southeast Asia Meningitis Treatment Market Analysis
Chapter 10 Middle East Meningitis Treatment Market Analysis
Chapter 11 Africa Meningitis Treatment Market Analysis
Chapter 12 Oceania Meningitis Treatment Market Analysis
Chapter 13 South America Meningitis Treatment Market Analysis
Chapter 14 Company Profiles and Key Figures in Meningitis Treatment Business
Chapter 15 Meningitis Treatment Market Forecast (2021-2027)
Chapter 16 Conclusions
Related Market Intelligence Reports:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027